AU2022901426A0 - Lipid Nanocarrier Vaccine - Google Patents

Lipid Nanocarrier Vaccine

Info

Publication number
AU2022901426A0
AU2022901426A0 AU2022901426A AU2022901426A AU2022901426A0 AU 2022901426 A0 AU2022901426 A0 AU 2022901426A0 AU 2022901426 A AU2022901426 A AU 2022901426A AU 2022901426 A AU2022901426 A AU 2022901426A AU 2022901426 A0 AU2022901426 A0 AU 2022901426A0
Authority
AU
Australia
Prior art keywords
lipid nanocarrier
vaccine
nanocarrier vaccine
lipid
nanocarrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901426A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RMIT University
Original Assignee
Royal Melbourne Institute of Technology Ltd
Filing date
Publication date
Application filed by Royal Melbourne Institute of Technology Ltd filed Critical Royal Melbourne Institute of Technology Ltd
Publication of AU2022901426A0 publication Critical patent/AU2022901426A0/en
Priority to PCT/AU2023/050449 priority Critical patent/WO2023225722A1/en
Pending legal-status Critical Current

Links

AU2022901426A 2022-05-26 2022-05-26 Lipid Nanocarrier Vaccine Pending AU2022901426A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050449 WO2023225722A1 (en) 2022-05-26 2023-05-26 Lipid nanocarrier vaccine

Publications (1)

Publication Number Publication Date
AU2022901426A0 true AU2022901426A0 (en) 2022-06-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3877521A4 (en) Lipid nanoparticle formulations
EP4045480A4 (en) Pharmaceutical formulations
EP3877522A4 (en) Lipid nanoparticle formulations
EP3900741A4 (en) Samrna vaccine and preparation method therefor
EP3919072A4 (en) Cancer vaccine preparation
EP3967649A4 (en) Lipid nanoparticle
EP4031143A4 (en) Therapeutic conjugates
EP3957328A4 (en) Lipid pharmaceutical preparation and application thereof
AU2022901426A0 (en) Lipid Nanocarrier Vaccine
EP3941219A4 (en) Saponin-based vaccine adjuvants
EP3908316A4 (en) Tlr4-tlr7 ligand formulations as vaccine adjuvants
EP3958972A4 (en) Therapeutic drug for dyskinesia
EP3903810A4 (en) Preparation including vaccine adjuvant
EP3787602A4 (en) Methods for the manufacture of liposomal drug formulations
EP3923981A4 (en) Vaccine adjuvants and formulations
EP4021925A4 (en) Methods of increasing vaccine efficacy
AU2021903076A0 (en) SARS-CoV2 Vaccine
AU2021902567A0 (en) Lipid nanoparticle formulations
AU2021900212A0 (en) Sars-CoV-2 vaccine antigens
AU2020904820A0 (en) Coronavirus vaccine
AU2020903781A0 (en) Pharmaceutical formulations
AU2020903780A0 (en) Pharmaceutical formulations
GB202210794D0 (en) Lipid formulations
AU2022296692A1 (en) Novel mrna vaccine for autoimmunity
TWI800878B (en) Drug set